Latisse is the first and only FDA-approved prescription treatment for longer, thicker and darker eyelashes. Inadequately short or thin eyelashes is a condition called hypotrichosis, but can be treated with the 16-week daily application of Latisse to gradually stimulate eyelash growth. Latisse is the brand name for the medication, bimatoprost, which was originally marketed as a prescription to treat glaucoma. Eyelash growth was an unexpected side effect, which eventually led to the creation of Latisse in 2008. Considering it was originally designed to treat the eyes, it is already proven a safe product that now has a clinically proven 80 percent effectiveness rate for patients. Patients that dab Latisse on their top lids each night before bed will start to see longer lashes after 4 weeks and full results are achieved in 16 weeks. The medication will automatically spread to the lower lashes when you blink. Over 1.5 million bottles were sold in one year, and it has become increasingly popular with its proven results, so popular in fact, they’ve made an app out of it.
It’s called “iLash Studio” and is designed for iPhones, iPods, and iPads only but can provide a potential patient with a visualization of what your eyelashes would look like if you used Latisse. The app is geared to help patients along with treatment tips and possible questions to ask your doctor and treatment tips. Potential patients will be able to read FAQ’s and a gallery with real women and their personal experiences with Latisse. There’s no need to purchase the medication or even be prescribed the medication before downloading Latisse.